The use of African horse sickness virus NS3 protein, expressed in bacteria, as a marker to differentiate infected from vaccinated horses.

The research article focuses on using the African horse sickness virus NS3 protein to distinguish between horses that are infected and those vaccinated against the virus.

Overview of the Research

The paper primarily concentrates on the following aspects:

• Cloning and sequencing segment 10 of the double-stranded RNA genome from African horse sickness virus serotype 4 (AHSV-4).
• Comparing nucleotide sequences to identify similarities between different serotypes of the virus.
• Cloning cDNA clones containing the coding region in a vector and expressing it in Escherichia coli.
• Utilizing the NS3 gene product synthesized as a fusion protein in a differential ELISA to differentiate between infected and vaccinated horses.

Elucidation of the Results

Understanding what the results revealed:

• The sequence of the coding region showed a length of 667 base pairs (bp).
• The nucleotide comparison showed a 95% sequence similarity between AHSV-4 and AHSV-9 serotypes, and 76% similarity between AHSV-4 and AHSV-3.
• The NS3 gene was expressed at a very high level as an insoluble fusion protein in E. coli.
• Utilization of the synthesized NS3 protein for differential ELISA proved successful in distinguishing between infected and vaccinated horses.

Potential Implications

What the outcomes of the research could mean:

• The recombinant NS3 protein could potentially be utilized as a diagnostic tool to differentiate between infected and vaccinated animals. This would be particularly beneficial because it would allow the mobility of vaccinated horses, thereby sourcing potential economical benefits.
• The knowledge of the high sequence similarity between different serotypes of AHSV could be valuable for further research into diagnostic tool development or understanding the virus’s pathogenesis.
• The successful cloning and expression of the NS3 protein in E.coli signifies the utilization of bacterial systems for recombinant protein production, which could also be applied for producing other recombinant proteins.